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Abstract: Apart from its angiogenic and vascular permeation activity, the vascular 
endothelial growth factor (VEGF) has been also reported as a potent neuronal protector. 
Newborn rats with low VEGF levels develop neuron degeneration, while high levels induce 
protective mechanisms in several neuropathological conditions. Phoneutria nigriventer spider 
venom (PNV) disrupts the blood-brain barrier (BBB) and causes neuroinflammation in 
central neurons along with excitotoxic signals in rats and humans. All these changes are 
transient. Herein, we examined the expression of VEGF and its receptors, Flt-1 and Flk-1 
in the hippocampal neurons following envenomation by PNV. Adult and neonatal rats were 
evaluated at time limits of 2, 5 and 24 h. Additionally, BBB integrity was assessed by 
measuring the expression of occludin, β-catenin and laminin and neuron viability was 
evaluated by NeuN expression. VEGF, Flt-1 and Flk-1 levels increased in PNV-administered 
rats, concurrently with respective mRNAs. Flt-1 and Flk-1 immunolabeling was nuclear in 
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neurons of hippocampal regions, instead of the VEGF membrane-bound typical location. 
These changes occurred simultaneously with the transient decreases in BBB-associated 
proteins and NeuN positivity. Adult rats showed more prominent expressional increases of 
the VEGF/Flt-1/Flk-1 system and earlier recovery of BBB-related proteins than neonates. 
We conclude that the reactive expressional changes seen here suggest that VEGF and 
receptors could have a role in the excitotoxic mechanism of PNV and that such role would 
be less efficient in neonate rats.  
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1. Introduction 
Spider venoms are rich sources of low molecular mass compounds with a wide range of 
pharmacological effects on ion channels, neurotransmitter receptors and transporters and consequently 
on synaptic transmission [1]. Phoneutria nigriventer spider venom (PNV) contains a plethora of 
pharmacologically active peptides which interfere with the physiology of the tetrodotoxin  
(TTX)-sensitive Na+ channels and block the Ca2+ and K+ channels. Therefore PNV-induced changes in 
the concentration of these ions affect the glutamate transporter, resulting in increased extracellular 
glutamate concentration [2,3]. Human victims of P. nigriventer spider bites and experimental animals 
display neuroexcitatory symptoms, which may include convulsion in severe cases, generally in 
children [4]. Studies have shown that PNV presence in the blood flow induces blood-brain barrier 
(BBB) breakdown in the hippocampus of rats [5] by enhanced transendothelial microtubule-mediated 
vesicular transport [6], or by displacement and/or decrease of proteins that control the paracellular 
pathway [7]. These effects are accompanied by transient neurotoxic manifestations. Despite clinical 
reports and experimental studies showing that P. nigriventer spiderenvenoming causes neurotoxic 
manifestations and induces permeation of the BBB, little is known about molecular mechanisms 
triggered in the brain shortly after envenomation. 
Increased BBB permeability has been associated with increased expression of angiogenic factors, 
the most notable of which is the vascular endothelial growth factor (VEGF) [8]. VEGF action results 
from binding to VEGFR1 and VEGFR2, also known as the Fms-like tyrosine kinase 1 (Flt-1) and fetal 
liver kinase 1/kinase insert domain receptor (Flk-1/KDR), respectively [9]. Increased VEGF levels 
have been described in brain repair [10] and in many pathological events affecting the central nervous 
system [11]. BBB disruption has been associated with pathologic angiogenesis in patients suffering 
from intractable temporal lobe epilepsy accompanied by overexpression of VEGF in neurons and Flk-1 
in endothelial cells [12]. It was thus considered of interest to investigate whether or not P. nigriventer 
experimental envenomation is accompanied by expressional changes in the VEGF/Flt-1/Flk-1 system. 
Since the hippocampus is rich in glutamate receptors and transporters and, as part of the temporal 
lobe is involved in the etiopathogenesis of convulsion-like events like those induced by PNV [4], it is 
important to focus on this region as a PNV target and seek possible ongoing molecular mechanisms 
coursing with the BBB permeation [13]. Thus far, studies on the BBB disruption by PNV have used 
adult rats, but age-related differences have been reported for humans [4] and recently reported for  
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rats [14]. Herein, a possible age-dependent differential response in relation to VEGF involvement is 
investigated using neonate and adult rats.  
This study will shed light on VEGF, Flt-1 and Flk-1 response generated by circulating  
P. nigriventer spider venom, running in parallel with the BBB breakdown. The fact that the effects are 
short-lived present good prospects for future studies aiming to promote transient BBB opening for 
therapeutic purposes. 
2. Results  
Irrespective of age, animals that were administered saline were normal in their feeding and 
behavioral habits in cages, whereas animals administered PNV displayed unevenly the toxic 
manifestations described by other authors, including piloerection, shivering, hypersalivation, 
respiratory distress, spastic hindlimb paralysis and tonic convulsion [5,13]. 
2.1. Blood-Brain Barrier-Associated Proteins: Occludin, β-Catenin, Laminin 
Occludin, β-catenin and laminin showed a relatively similar pattern of response to PNV 
envenomation. All decreased significantly and transiently in adult and neonate rats exposed to PNV, 
with such decreases occurring earlier in adults than in neonates, after which they exhibited recovery 
towards baseline (Figure 1A–C). 
Relative to respective control levels, occludin expression decreased significantly earlier in adults  
(2 h) than in neonates (5 h) and showed a 28% decrease (* p ≤ 0.05) compared with a 30% decrease in 
neonates (*** p ≤ 0.001); there was no difference between PNV vs. controls in protein expression at  
24 h (Figure 1A). PNV-administered adult rats showed immediate (2 h) 55% downregulation of  
β-catenin (* p ≤ 0.05), whereas downregulation in neonates occurred at 5 h and was 20% in magnitude 
(* p ≤ 0.05). These changes were transitory given that at 24 h protein expression was close to baseline 
for rats of both ages (Figure 1B). The reduction of laminin expression was higher (73%, * p ≤ 0.05) 
and earlier (2 h) in adult rats administered PNV than in matched neonates (5 h, 9% reduction,  
* p ≤ 0.05) (Figure 1C). Laminin expression was lower in adult rats in comparison with neonates for 
both control and PNV groups. There were age-related differences in laminin expression between  
PNV-treated rats at 2 h (### p ≤ 0.001) and 5 h (## p ≤ 0.01), as illustrated in Figure 1. 
2.2. Immunohistochemistry: PNV Increased VEGF, Flt-1, Flk-1 Immunostaining 
Figure 2 illustrates the VEGF, Flt-1 and Flk-1 staining pattern in the CA1 subfield of the 
hippocampus of adult rats taken at 5 h after i.p. administration of saline or PNV. Under control 
conditions (saline), VEGF was expressed in pyramidal neuron bodies and dendrites of the CA1, CA2 
and CA3 and granule neurons of the dentate gyrus (DG). Flt-1 and Flk-1 receptors were mainly 
expressed in the nuclei of pyramidal and granule neurons. Flt-1 staining was also seen in neuron 
processes. Flt-1 staining was stronger than that of Flk-1. Such a pattern was mirrored by CA2, CA3 
and DG hippocampal subfields for rats of both ages. 
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Figure 1. Immunoblots of occludin (A), β-catenin (B) and laminin (C). Phoneutria nigriventer 
(PNV) intra-peritoneal (i.p) injection induced significant decreases of all three proteins at  
2 h for adults, whereas at 5 h for neonates. * p ≤ 0.05 and *** p ≤ 0.001 denote significant 
decreases relative to controls; ## p ≤ 0.01 and ### p ≤ 0.001 indicate PNV-treated neonates 
with higher increase in laminin expression than their adult counterpart at 2 and 5 h.  
Student t-test; data are shown as means ± SEM. 
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Figure 2. CA1 subfield of 8–10-week-old rats: composite photomicrographs of 
hippocampal coronal sections stained for localization of anti-VEGF, anti-Flt-1 and  
anti-Flk-1 and using the immunoperoxidase technique. (A,C,E) are sections from controls 
(saline-treated) and (B,D,F) are from PNV-treated adult rats 5 h after i.p. injection. PNV 
increased the immunoreactivity of VEGF, Flt-1 and Flk-1. Py = stratum pyramidale;  
Or = stratum oriens; Rad = stratum radiatum; * = microvessels with perivascular edema. 
Scale Bars = 25 µm.  
 
The immunostaining of VEGF and Flt-1 and Flk-1 receptors was increased in all the subfields of 
hippocampus of PNV-treated rats of both ages. Figure 2 (panels A to F) depicts CA1 subfield of adult 
rats injected with saline and PNV as representative of the staining pattern exhibited by the other 
subfields. Consistently, anti-Flt-1 staining increased more prominently than VEGF and Flk-1. While 
several nuclei were Flk-1 negative (Figure 2F), practically all nuclei were Flt-1 positive (Figure 2D) 
and all neuron bodies were VEGF positive (Figure 2B). A similar staining pattern was observed in 
PVN-treated P14 rats (not shown). 
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It should be mentioned that the microcirculation vessels of PNV-administered animals presented 
perivascular edema in all the hippocampal subfields examined (Figure 2B,D,F as representatives) 
confirming previous quantitative studies [5,13,14]. 
2.3. Western Blotting and Real-Time Polymerase Chain Reaction (PCR): Temporal and  
Age-Related Differences 
VEGF, Flt-1 and Flk-1 expression in the hippocampus homogenate (comprising all ammonic 
subfields together, CA1, CA2, CA3) and DG showed time- and age-dependent differences in  
PNV-administered rats. 
2.3.1. VEGF, Flt-1 and Flk-1 Immunoblot Quantification 
In the hippocampus of PNV-treated adult rats, VEGF increased by 36% at 24 h, but not for neonates 
(Figure 3A; * p ≤ 0.05). VEGF expression, basally and after venom exposure, was higher in neonates 
than in adults, being 70% significantly higher at 2 h in neonates than in envenomed adults (## p ≤ 0.01) 
and 42% significantly higher at 5 h in neonates than control adults (# p ≤ 0.05). 
At 24 h, Flt-1 expression was 40% higher in PNV-treated P14 rats (*** p ≤ 0.001), whereas it was 
25% lower in PNV-treated adults at 2 h relative to baseline (Figure 3B; * p ≤ 0.05). At 24 h post-PNV,  
Flt-1 expression was higher in neonates than in adults (## p ≤ 0.01). Flk-1 expression level was 
upregulated by 50% in adult rats after 5 h, relative to baseline (* p ≤ 0.05, Figure 3C), and remained 
unchanged in neonates. 
Three-way ANOVA analysis revealed interaction between treatment vs. time variables so 
influencing the expression of VEGF and Flt-1 (* p ≤ 0.05). 
2.3.2. VEGF, Flt-1 and Flk-1 mRNAs (qPCR) 
In adult rats treated with PNV, VEGF mRNA showed a 27% increase at 5 h (Figure 4A), Flt-1 
mRNA expression showed a 15% decrease at 2 h, followed by increases of 15% and 5% at 5 h  
and 24 h, respectively (* p ≤ 0.05) and Flk-1 mRNA showed a 15% increase at 5 h (** p ≤ 0.01,  
Figure 4B,C). In envenomed neonates, only Flk-1 mRNA expression was 12% above control at 24 h 
(** p ≤ 0.01, Figure 4B,C). 
Age-related comparison showed that at 5 and 24 h VEGF mRNA expression in adult rats was, 
respectively, 12% and 18% above the level found in envenomed neonates (# p ≤ 0.05). In contrast,  
Flt-1 mRNA was higher in neonates than in adults at 2 and 5 h (# p ≤ 0.05) and the Flk-1  
mRNA level was higher in adults than in neonates at 2, 5 and 24 h (# p ≤ 0.05, ### p ≤ 0.001 and  
## p ≤ 0.01, respectively). 
The three-way ANOVA analysis showed that interaction between two variables influenced the third 
variable for expression of VEGF, Flt-1 and Flk-1 mRNAs (* p ≤ 0.05). 
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Figure 3. Western blot signals were densitometrically quantified and normalized to an 
internal standard (β-actin). VEGF (A), Flt-1 (B) and Flk-1 (C) expressions in PNV-treated 
samples (1.7 mg/kg) relative to control (CTR); * p ≤ 0.05 and *** p ≤ 0.001 indicate 
significant difference relative to respective controls; # p ≤ 0.05 and ## p ≤ 0.01 denote 
significant age-related differences between control (CTR) or PNV-treated groups at 
corresponding time-point. Student t-test; data were shown as means ± SEM. 
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Figure 4. Quantitative real-time polymerase chain reaction (PCR) analysis quantified and 
normalized to endogen control (GAPDH). VEGF (A), Flt-1 (B) and Flk-1 (C) mRNAs 
expression at time-points after PNV (1.7 mg/kg) or 0.9% saline peritoneal injection.  
* p ≤ 0.05 and ** p ≤ 0.01 indicate significant difference relative to respective controls;  
# p ≤ 0.05, ## p ≤ 0.01 and ### p ≤ 0.001, denote significant age-related differences between 
control (CTR) or PNV-treated groups at corresponding time-point. Student t-test; data were 
shown as means ± SEM. 
 
2.4. NeuN Immunohistochemistry and Western Blotting 
NeuN was expressed in the nuclei of pyramidal and granule neurons. Figure 5 illustrates anti-NeuN 
labeling in the hippocampal CA2 region of an adult rat treated with saline (panel A) and PNV (panel B). 
Figure 5C shows the time-course quantification of the density of pixels, expressed as percentage, of 
NeuN-labeled neurons in CA1, CA2, CA3 and DG regions of PNV-exposed rats and control rats.  
Anti-NeuN upregulation reached significance at 24 h only for neonates as follows: 88% in CA3  
(** p ≤ 0.01) > 65% in CA2 (* p ≤ 0.05) > 50% in DG (* p ≤ 0.05) > 46% in CA1 (* p ≤ 0.05). The 
NeuN level of envenomed adults was similar to their baseline values. Age-related differences 
demonstrated that neonate animals showed a tendency to exhibited higher levels of NeuN than adult 
rats which also reached significance at 24 h (# p ≤ 0.05; ## p ≤ 0.01; ### p ≤ 0.001). 
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Figure 5. NeuN labeling in the CA2 subfield of 8–10-week-old rats 5 h after i.p. injection 
of saline solution (A) or PNV (B). Py = stratum pyramidale; Or = stratum oriens;  
Rad = stratum radiatum; * = microvessels with perivascular edema. (C) Percentage of pixel 
density of NeuN-labeled neurons in different time points. (D) Immunoblots of NeuN in the 
hippocampus of i.p.-injected saline or PNV rats at 2, 5 and 24 h. * p ≤ 0.05 and ** p ≤ 0.01 
denote significant decrease of the nuclear marker relative to respective controls; # p ≤ 0.05,  
## p ≤ 0.01 and ### p ≤ 0.001) denote significant difference in NeuN expression between 
control (CTR) or PNV-treated groups at the corresponding time-point. Student t-test; data 
were shown as means ± SEM. Scale Bars = 25 µm. 
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Western blot analyses of NeuN showed an 18% decrease at 5 h (** p ≤ 0.01) and a 15% increase at  
24 h (** p ≤ 0.01) in PNV-treated neonate rats (Figure 5D). In adults, NeuN level was 20% downregulated 
at 2 h (** p ≤ 0.01), and was similar to baseline values at 5 h and 24 h. There were age-related differences 
between PNV-treated adult and neonate rats at 2 h and 5 h, with neonates showing higher levels than 
adults, as illustrated in Figure 5 (26%, ## p ≤ 0.01 and 20%, # p ≤ 0.05, respectively). 
3. Discussion 
Despite clinical and experimental studies having shown that P. nigriventer spider envenomation 
induces neuroexcitotoxic signals, and that the venom disrupts the blood-brain barrier, causes reactive 
astrogliosis, neuroinflammation, and activates neurons [4,5,15,16], little is known about regulatory 
mechanisms triggered in the brain shortly after envenomation.  
VEGF type A, studied herein, is a hypoxia-inducible glycoprotein with a pivotal pro-angiogenesis 
regulator role [17,18]. VEGF is promptly upregulated in response to minimal changes in oxygen [19] and 
is therefore considered to be a neurotrophic/neuroprotective cytokine against brain damage [17,20,21]. 
VEGF translational regulation is accomplished through endogenous mechanisms that activate the 
oxygen-regulated α-subunit of hypoxia-inducible transcription factor-1 (HIF-1) [22]. In rats, intoxication 
by PNV includes neuroexcitability, respiratory distress, and convulsion [5,13,14], which all together 
lead to the loss of energy homeostasis in the CNS. Although both neonate and adult rats presented 
similar signs of intoxication, the results of the present study suggest that, following exposure to PNV, 
neonate rats seem to be less capable than adult rats in activating VEGF, Flt-1 and Flk-1 promoters, to 
produce mRNAs with efficient translational activity. 
In fact, in neonates, only Flk-1 mRNA and Flt-1 protein increased, with this occurring later, at 24 h, 
while VEGF and Flt-1 mRNAs and VEGF and Flk-1 proteins remained unaltered. In contrast, in  
PNV-treated adult rats, VEGF mRNA and Flk-1 mRNA expression increased at 5 h, and Flt-1 mRNA 
increased at 5 and 24 h. The absence of changes and/or delayed response by envenomed neonates  
may suggest immature endogenous mechanism for activation of HIF-1 and translational regulation of 
VEGF, a hypothesis that requires further examination. Until now, studies of the effect of PNV on BBB 
have been conducted only with adult rats, but age-related differences have been recently reported for 
both rats [14,23] and humans [4]. 
The changes in the VEGF/Flt-1/Flk-1 system shown here were concurrent with hippocampal 
microvascular permeability, evidenced by perivascular edema and supported by expressional decreases 
of proteins associated with BBB, such as occludin, β-catenin and laminin. These findings are in line 
with previous quantitative results that have shown BBB disruption, vasogenic and cytotoxic edema in 
the hippocampus and cerebellum of rats given PNV [5,13,15,16]. Interestingly, redistribution of 
occludin, β-catenin and laminin occurred later in neonates (5 h) than in adults (2 h), and changes in 
their expression was in general less pronounced in neonates than in adults. Such findings substantiate 
the view that endogenous regulatory mechanisms against PNV toxicity seems to be more precarious in 
neonates than in adults. The data obtained in the present study agree with study showing that BBB in 
suckling rats, like P14, is immature and that differentiation of endothelial cells of brain vessels is not 
yet accomplished [24]. 
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Another study suggests that transcription factors such as HIF-1 are an upstream mediator of 
junctional proteins during hypoxia, which may involve VEGF induction and expression [25]. Like 
HIF-1, VEGF at the BBB is considered a permeability mediator [11]. This is in keeping with VEGF 
function as a potent inducer of vascular permeability during strokes, ischemia and other conditions of 
oxygen brain deprivation. Additionally, changes in BBB-associated proteins have been reported in 
similar pathological states; and perivascular edema has been related to BBB leakage [8,26]. Activated 
Flt-1 and Flk-1 receptors stimulate a variety of signaling pathways and extensive biological responses 
in endothelial cells [27], but not exclusively. Studies have shown VEGF participation in vascular, glial 
and neural cells, the glio-neurovascular unit (g-NVu), to which BBB is integrated [28,29]. In previous 
studies, the authors of the present study have shown that PNV activates neurons (Fos induction) and 
causes neuroinflammation (induction of pro-inflammatory cytokines) [15,16], hence demonstrating that 
the venom affects all cell types of the g-NVu. 
The reduction at 5 h of NeuN expression in the hippocampus of PNV-treated neonates followed by 
increase at 24 h (see WB- and immunochemistry-based data) could be associated with the upregulation 
of Flt-1 expression and Flk-1 mRNA at the same 24 h in these animals. The release of neurotrophic 
factors could result in a higher number of living neurons. VEGF signaling through Flt-1 and Flk-1 
receptors has been positively implicated in the synaptic plasticity during adulthood, developmental and 
post-developmental stages of neurons; also current knowledge refers the role of VEGF in both the 
synapse formation and elimination implying a differential interaction of the neurotrophic factor with 
different subtypes of neurons [30]. Whether these differential effects correlate with the expression of 
specific sets of VEGF receptors in groups of neurons was not investigated yet. NeuN is a central 
element of the neuronal nuclear matrix that is only expressed in post-mitotic neurons [31]; it has been 
used as a marker of mature neurons and neuron viability [32]. 
Pyramidal neurons are the most abundant neuronal type located in forebrain structures, including 
the cerebral cortex, hippocampus and amygdala. Their location in the forebrain region indicates 
involvement with higher cognitive function. Conversely, the dentate gyrus of the hippocampus is a key 
relay station, common to all animals, which controls the transfer of information from the entorhinal 
cortex to the hippocampus proper [33,34]. Dentate gyrus granule neurons play a seminal role in  
this process, as they receive and integrate entorhinal synaptic inputs. The complex is involved in 
seizure-like events. Both pyramidal dendrites and granule dendrites possess N-methyl-D-aspartate 
(NMDA) receptors, and Na+ and Ca2+ channels, and therefore the possibility of being affected by ion 
channel acting-neuropeptides of PNV [3] is not excluded. Neuropeptides of PNV contain a calcium 
channel antagonist that blocks glutamate exocytosis but also inhibits glutamate uptake [35–37]  
in synaptosomes. VEGF modulates NMDA receptor activity in cerebellar granule cells through  
Src-family kinases before synapse formation [38] reduces calcium influx via inhibition of the Ca2+ 
channels in rat hippocampal neurons [39] and controls epileptic activity by influencing glutamatergic 
and gamma-aminobutyric acid (GABA)ergic neurotransmission [40,41]. Taking into account the  
fact that pyramidal and granule neurons NeuN(+) are VEGF(+), Flt-1(+) and Flk-1(+) cells, and 
considering the pharmacological characteristics of PNV, the changes in the expression of these 
proteins in the course of envenomation may represent their potential involvement in the hippocampus 
at the initial phases of envenomation by PNV. However, such supposition requires examination since 
the findings here found could be causal in nature. 
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Finally, the unexpected reactivity of anti-Flt-1 and Flk-1 in the nuclei of neurons is interesting. Like 
VEGF, the receptors typically exhibit a membrane-bound location. However, several studies have 
demonstrated that receptors can be translocated to the nucleus in both physiological and pathological 
conditions. Translocation of functional growth factor receptors to the cell nucleus has been considered 
a novel mechanism for growth factor regulation. Ligand binding can internalize the activated receptors 
to downregulate signaling through degradation of the ligand/receptor complex (ubiquitinylation) or  
via endocytosis of the receptor itself [42,43]. Although unclear, it is possible that the age-related 
differences in the expression of VEGF and its tyrosine kinase receptors in response to PNV observed 
herein may reflect differences in the internalization and subsequent nuclear trafficking of the receptors, 
thereby inpacting cellular processes in the hippocampal tissue. 
4. Experimental Section 
4.1. Animals and Venom 
Male Wistar rats (Rattus norvegicus) aged three weeks were obtained from the Multidisciplinary 
Center for Biological Investigation at the State University of Campinas (CEMIB/Unicamp). They were 
housed under standard animal colony conditions, 5 per cage, at 23 °C on a 12 h light/dark cycle, with 
lights on at 6 a.m. and with free access to food and water until reaching 8–10 weeks old. At least 24 h 
before the experiment, the animals were transported in their home cages from the animal colony to the 
laboratory and allowed to habituate. Male Wistar rats on post-natal day 14 (P14) were taken directly 
from CEMIB to the laboratory, and experiments were done in the next day. Lyophilized P. nigriventer 
crude venom (PNV) was stored at −20 °C, until use.  
4.2. Envenoming Procedure 
All experimental procedures were approved by the Institutional Committee for Ethics in Animal 
Use (CEUA/IB/Unicamp, protocol n. 2403-1) and the experiments were carried out according to the 
established by the Brazilian Society of Laboratory Animal Science (SBCAL) guidelines for animal 
use. P14 animals (n = 4–6) and 8–10 weeks old animals (n = 4–6) received a single intraperitoneal 
(i.p.) injection of PNV (1.7 mg/kg in 0.5 mL of 0.9% sterile saline), while the control group was  
given the same volume of vehicle [14]. Two, five and 24 h after saline or PNV i.p. administration, the 
animals were anesthetized and the hippocampus immediately removed. Neonate rats were used for 
comparison with adult rats, since severe accidents by Phoneutria generally occurs in children [4]. 
Time limits of 2, 5 and 24 h corresponded to periods of peak of intoxication, beginning of clinical 
recovery and no sign of intoxication at all, respectively [14]. 
4.3. Immunohistochemistry and Image Analysis 
Anti-VEGF (1:50, mouse monoclonal, sc-7269), anti-Flt-1 (1:500, rabbit polyclonal, sc-316) and 
Flk-1 (1:50, rabbit polyclonal, sc-315), all from Santa Cruz Biotechnology (Santa Cruz, CA, USA), 
and anti-neuronal nuclear antigen (NeuN) (1:1000, rabbit polyclonal, ABN78, Millipore, Billerica, 
MA, USA) immunohistochemistry were performed in coronal sections of the hippocampus, as 
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previously described [14]. Negative control was done with 1% PBS-bovine serum albumin (BSA) but 
without the primary antibody. 
NeuN levels were determined as previously described [14], using the free access GIMP 2.6.4 
software (GNU Image Manipulation Program, CNE, Free Software Foundation, Boston, MA, USA). 
4.4. Western Blotting (WB) 
After 2, 5 and 24 h of PNV or saline injection, the animals (n = 6/time), were anaesthetized by CO2 
inhalation and killed by decapitation. The hippocampi from each group were quickly dissected and 
homogenized in an extraction buffer (10 mM EDTA, 2 mM PMSF, 100 mMNaF, 10 mM sodium 
pyrophosphate, 10 mM NaVO4, 0.1 mg of aprotinin/mL and 100 mMTris, pH 7.4). Cellular protein 
was quantified by Bradford assay (Bio-Rad, Hercules, CA, USA), then 40 µg of the cleared lysates 
were separated on 8% (β-catenin, Flt-1, Flk-1, laminin and occludin) or 12% (VEGF and NeuN)  
SDS-PAGE and electrotransferred onto nitrocellulose membrane (BioRad). Total cell lysates were 
prepared and analyzed by Western blotting, as previously described [7]. Antibodies were specific for 
rabbit polyclonal antibody against Flt-1 (1:500, sc-316), Flk-1 (1:250, sc-315, Santa Cruz, CA, 
USA),laminin (1:500, L9393, Sigma Aldrich, St. Louis, MO, USA), NeuN (1:2000, ABN78, Millipore, 
Billerica, MA, USA); mouse monoclonal antibody against β-Catenin (1:600, sc-7963) and VEGF (1:500, 
sc-7269) (Santa Cruz, CA, USA), β-actin (1:1,000, A2228, Sigma Aldrich) and goat monoclonal 
antibody against occludin (1:500, sc-8144, Santa Cruz, CA, USA). Bands were visualized using 
chemiluminescence reagent (Thermo Scientific, Waltham, MA, USA). For quantification, the density 
of pixels of each band was determined by the NIH Image J 1.45s software (available at ftp from 
zippy.nimh.nih.gov/ or from http://rsb.info.nih.gov/nih-image; developed by Wayne Rasband, NIH, 
Bethesda, MD, USA). The results of each protein were confirmed in three sets of experiments, and 
data were normalized using the respective loading controls. Values were normalized to the 
corresponding value for β-actin and expressed as a ratio. 
4.5. RNA Isolation and Real-Time Quantitative Polymerase Chain Reaction (qPCR) 
Total RNA was isolated from the hippocampus of each group using trizol reagent (Life 
Technologies, Gaithersburg, MD, USA). Primers used in this study and their respective assay 
identification numbers in the Applied Biosystem catalog were: VEGF: Rn01511601_m1, Flt-1: 
Rn00570815_m1, Flk-1: Rn00564986_m1. The levels of VEGF, Flt-1 and Flk-1 mRNA were 
quantitated relative to amplicon-specific standard curves by qPCR using 50 ng total RNA in triplicate 
and analyzed on an ABI Prism 7500 sequence detector, using a TaqMan® Universal Master Mix. The 
optimal concentrations of cDNA and primers, as well as the maximum efficiency of amplification, 
were obtained by five-point, two-fold dilution curve analysis for each gene. Each PCR contained  
3.0 ng of reverse-transcribed RNA, 200 nM of each specific primer, SYBR SAFE PCR master mix, 
and RNase-free water to a final volume of 20 µL. All samples were run in triplicate with water as a  
no-template control and GAPDH as an endogenous control. Real-time data were analyzed using the 
Sequence Detection System 1.7 (Applied Biosystems, Carlsbad, CA, USA). 
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4.6. Statistics 
Student’s t-test was used for comparisons between PNV and control data. Additionally, three-way 
ANOVA test was used to determine the influence of three variables (treatment (control and PNV), age 
(P14 and 8–10 weeks) and time (2, 5, and 24 h)) on the resulting outcome. The data were expressed as 
the mean ± SEM; a p ≤ 0.05 indicated significance. 
5. Conclusions 
Overall, the data showed that the changes in the expression of VEGF, Flt-1, Flk-1 and their 
respective mRNAs in the hippocampus of rats administered with the venom of P. nigriventer spider 
were time- and age-dependent. These changes were concurrent with decreased proteins associated  
with BBB, occludin, β-catenin and laminin, simultaneously with the appearance of perivascular edema. 
Neonate rats seem to be more susceptible than adult rats. PNV-treated neonate rats showed increased 
NeuN expression. All the expressional changes showed age-related pace, with adult response more 
precocious (2 h) than that of neonates (5 h). Together, the findings suggest an interdependent and 
suggestively time-coordinated sequence of events. VEGF, Flt-1, Flk-1 and NeuN were expressed by 
pyramidal and granule neurons. Flt-1 and Flk-1 atypically exhibited nuclear translocation, with this 
hypothetically being a potential mechanism for regulating VEGF. Studies have shown that PNV 
induces excitotoxic signs which follow BBB breakdown and probably central energy unbalance. PNV 
possesses ion channel-acting neuropeptides that interfere with neurotransmission and glutamate 
handling. Future pharmacological studies are needed to reveal which interdependent signaling 
pathways underlie VEGF and the intracellular tyrosine kinase domains of Flt-1 and Flk-1 in the 
neurotoxic manifestations elicited by PNV. This will elucidate the actual role of VEGF in PNV-related 
hippocampal changes. 
Acknowledgments 
This work was supported by the State of São Paulo Research Foundation (Fapesp #2008/55748-1) 
and the National Council for Scientific and Technological Development (CNPq #305099/2011-6, 
302206/2008-6 and 481316/2008-6). M.C.P.M. was supported by a M.Sc. studentship from the 
Coordination of Improvement of Higher Level Personnel (Capes) and M.A.C.H. is a 1A researcher 
fellow of CNPq. We gratefully acknowledge Lício Augusto Velloso for laboratory facilities, Stephanie 
SoutoMaior for technical assistance, and Miguel Silva for excellent animal care. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. Vassilevsky, A.A.; Koslov, S.A.; Egorov, T.A.; Grishin, E.V. Purification and characterization of 
biologically active peptides from spider venoms. Methods Mol. Biol. 2010, 615, 87–100. 
Toxins 2013, 5 2586 
 
 
2. Reis, H.J.; Prado, M.A.; Kalapothakis, E.; Cordeiro, M.N.; Diniz, C.R.; de Marco, L.A.;  
Gomez, M.V.; Romano-Silva, M.A. Inhibition of glutamate uptake by a polypeptide toxin 
(phoneutriatoxin 3–4) from the spider Phoneutria nigriventer. Biochem. J. 1999, 343, 413–418. 
3. Gomez, M.V.; Kalapothakis, E.; Guatimosim, C.; Prado, M.A. Phoneutria nigriventer venom: A 
cocktail of toxins that affect ion channels. Cell. Mol. Neurobiol. 2002, 22, 579–588. 
4. Bucaretchi, F.; Deus Reinaldo, C.R.; Hyslop, S.; Madureira, P.R.; de Capitani, E.M.; Vieira, R.J. 
A clinico-epidemiological study of bites by spiders of the genus Phoneutria. Rev. Inst. Med. Trop. 
São Paulo 2000, 42, 17–21. 
5. Le Sueur, L.; Kalapothakis, E.; Cruz-Höfling, M.A. Breakdown of the blood-brain barrier and 
neuropathological changes induced by Phoneutria nigriventer spider venom. Acta Neuropathol. 
2003, 105, 125–134. 
6. Le Sueur, L.; Collares-Buzato, C.B.; Cruz-Höfling, M.A. Mechanisms involved in the blood-brain 
barrier increased permeability induced by Phoneutria nigriventer spider venom in rats. Brain Res. 
2004, 1027, 38–47. 
7. Rapôso, C.; Odorissi, P.A.M.; Oliveira, A.L.R.; Aoyama, H.; Ferreira, C.V.; Verinaud, L.; 
Fontana, K.; Ruela-de-Sousa, R.R.; da Cruz-Höfling, M.A. Effect of Phoneutria nigriventer 
venom on the expression of junctional protein and P-gp efflux pump function in the blood-brain 
barrier. Neurochem. Res. 2012, 37, 1967–1981. 
8. Nag, S.; Kapadia, A.; Stewart, D.J. Review: Molecular pathogenesis of blood-brain barrier 
breakdown in acute brain injury. Neuropathol. Appl. Neurobiol. 2011, 37, 3–23. 
9. Olsson, A.K.; Dimberg, A.; Kreuger, J.; Claesson-Welsh, L. VEGF receptor signaling in control 
of vascular function. Nat .Rev. Mol. Cell Biol. 2006, 7, 359–371. 
10. Sköld, M.K.; Risling, M.; Holmin, S. Inhibition of vascular endothelial growth factor receptor 2 
activity in experimental brain contusions aggravates injury outcome and leads to early increased 
neuronal and glial degeneration. Eur. J. Neurosci. 2006, 23, 21–34. 
11. Ruiz de Almodovar, C.; Lambrechts, D.; Mazzone, M.; Carmeliet, P. Role and therapeutic 
potential of VEGF in the nervous system. Physiol. Rev. 2009, 89, 607–648. 
12. Morin-Brureau, M.; Rigau, V.; Lerner-Natoli, M. Why and how to target angiogenesis in focal 
epilepsies. Epilepsia 2012, 53, 64–68. 
13. Rapôso, C.; Zago, G.M.; Silva, G.H.; Cruz-Höfling, M.A. Acute blood brain barrier permeabilization 
in rats after systemic Phoneutria nigriventer venom. Brain Res. 2007, 1149, 18–29. 
14. Mendonça, M.C.; Soares, E.S.; Stávale, L.M.; Irazusta, S.P.; Cruz-Höfling, M.A. Upregulation of 
the vascular endothelial growth factor, Flt-1, in rat hippocampal neurons after envenoming by 
Phoneutria nigriventer; age-related modulation. Toxicon 2012, 60, 656–664.  
15. Cruz-Höfling, M.A.; Zago, G.M.; Melo, L.L.; Rapôso, C. C-FOS and n-NOS reactive neurons in 
response to circulating Phoneutria nigriventer spider venom. Brain Res. Bull. 2007, 73, 114–126. 
16. Cruz-Höfling, M.A.; Rapôso, C.; Verinaud, L.; Zago, G.M. Neuroinflammationand astrocytic 
reaction in the course of Phoneutria nigriventer (armed-spider) blood-brain barrier (BBB) 
opening. Neurotoxicology 2009, 30, 636–646. 
17. Jin, K.; Zhu, Y.; Sun, Y.; Mao, X.O.; Xie, L.; Greenberg, D.A. Vascular endothelial growth  
factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2002, 99, 
11946–11950. 
Toxins 2013, 5 2587 
 
 
18. Ferrara, N.; Gerber, H.P.; le Couter, J. The biology of VEGF and its receptors. Nat. Med. 2003, 9, 
669–676. 
19. Semenza, G. Signal transductions to hypoxia-inducible factor 1. Biochem. Pharmacol. 2002, 64, 
993–998. 
20. Góra-Kupilas, K.; Jośko, J. The neuroprotective function of vascular endothelial growth factor 
(VEGF). Folia Neuropathol. 2005, 43, 31–39. 
21. Zachary, I. Neuroprotective role of vascular endothelial growth factor: Signaling mechanisms, 
biological function, and therapeutic potential. Neurosignals 2005, 14, 207–221. 
22. Ogunshola, O.O.; Al-Ahmad, A. HIF-1 at the blood-brain barrier: A mediator of permeability? 
High Alt. Med. Biol. 2012, 13, 153–161. 
23. Stávale, L.M.; Soares, E.S.; Mendonça, M.C.; Irazusta, S.P.; da Cruz Höfling, M.A. Temporal 
relationship between aquaporin-4 and glial fibrillary acidic protein in cerebellum of neonate and 
adult rats administered a BBB disrupting spider venom. Toxicon 2013, 66, 37–46. 
24. Risau, W.; Esser, S.; Engelhardt, B. Differentiation of blood-brain barrier endothelial cells. 
Pathol. Biol. 1998, 46, 171–175. 
25. Witt, K.A.; Mark, K.S.; Hom, S.; Davis, T.P. Effects of hypoxia-reoxygenation on rat blood-brain 
barrier permeability and tight junctional protein expression. Am. J. Physiol. Heart Circ. Physiol. 
2003, 285, H2820–H2831. 
26. Nico, B.; Ribatti, D. Morphofunctional aspects of the blood-brain barrier. Curr. Drug Metab. 
2012, 13, 50–60. 
27. Zachary, I.; Gliki, G. Signaling transduction mechanism mediating biological actions of the 
vascular endothelial growth factor family. Cardiovasc. Res. 2001, 49, 568–581. 
28. Neuwelt, E.; Abbott, N.J.; Abrey, L.; Banks, W.A.; Blakley, B.; Davis, T.; Engelhardt, B.; 
Grammas, P.; Nedergaard, M.; Nutt, J.; et al. Strategies to advance translational research into 
brain barriers. Lancet Neurol. 2008, 7, 84–96. 
29. Zlokovic, B.V. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other 
disorders. Nat. Rev. Neurosci. 2011, 12, 723–738. 
30. Tillo, M.; Ruhrberg, C.; Mackenzie, F. Emerging roles for semaphorins and VEGFs in 
synaptogenesis and synaptic plasticity. Cell Adhes. Migr. 2012, 6, 541–546. 
31. Dent, M.A.; Segura-Araya, E.; Alva-Medina, J.; Aranda-Anzaldo, A. NeuN/Fox-3 is an intrinsic 
component of the neuronal nuclear matrix. FEBS Lett. 2010, 584, 2767–2771. 
32. Snyder, J.S.; Ferrante, S.C.; Cameron, H.A. Late maturation of adult-born neurons in the temporal 
dentate gyrus. PLoS One 2012, 7, e48757. 
33. Amaral, D.G.; Scharfman, H.E.; Lavenex, P. The dentate gyrus: Fundamental neuroanatomical 
organization (dentate gyrus for dummies). Prog. Brain Res. 2007, 163, 3–22. 
34. Treves, A.; Tashiro, A.; Witter, M.E.; Moser, E.I. What is the mammalian dentate gyrus good for? 
Neuroscience 2008, 154, 1155–1172. 
35. Prado, M.A.; Guatimosim, C.; Gomez, M.V.; Diniz, C.; Cordeiro, M.N.; Romano-Silva, M.A. A 
novel tool for the investigation of glutamate release from rat cerebrocorticalsynaptosomes: The 
toxin Tx3–3 from the venom of the spider Phoneutria nigriventer. Biochem. J. 1996, 314 (Pt 1), 
145–150. 
Toxins 2013, 5 2588 
 
 
36. Vieira, L.B.; Kushmerick, C.; Reis, H.J.; Diniz, C.R.; Cordeiro, M.N.; Prado, M.A.; Kalapothakis, E.; 
Romano-Silva, M.A.; Gomez, M.V. PnTx3–6 a spider neurotoxin inhibits K+-evoked increase  
in Ca2+(i) and Ca2+-dependent glutamate release in synaptosomes. Neurochem. Int. 2003, 42,  
277–282. 
37. Mafra, R.A.; Figueiredo, S.G.; Diniz, C.R.; Cordeiro, M.N.; Cruz, J.D.; de Lima, M.E. PhTx4, a 
new class of toxins from Phoneutria nigriventer spider venom inhibits the glutamate uptake in rat 
brain synaptosomes. Brain Res. 1999, 831, 297–300. 
38. Meissirel, C.; Ruiz de Almodovar, C.; Knevels, E.; Coulon, C.; Chounlamountri, N.; Segura, I.; 
de Rossi, P.; Vinckier, S.; Anthonis, K.; Deléglise, B.; et al. VEGF modulates NMDA receptors 
activity in cerebellar granule cells trough Src-family kinases before synapse formation.  
Proc. Natl. Acad. Sci. USA 2011, 108, 13782–13787. 
39. Ma, Y.Y.; Li, K.Y.; Huang, Y.L.; Huang, Y.; Sun, F.Y. Vascular endothelial growth factor 
acutely reduces calcium influx via inhibition of the Ca2+ channels in rat hippocampal neurons.  
J. Neurosci. Res. 2009, 87, 393–402. 
40. Bogaert, E.; van Damme, P.; Poesen, K.; Dhondt, J.; Hersmus, N.; Kiraly, D.; Scheveneels, W.; 
Robberecht, W.; van den Bosch, L. VEGF protects motor neurons against excitotoxicity by 
upregulation of GluR2. Neurobiology 2010, 31, 2185–2191. 
41. Cammalleri, M.; Martini, D.; Ristori, C.; Timperio, A.M.; Bagnoli, P. Vascular endothelial 
growth factor up-regulation in the mouse hippocampus and its role in the control of epileptiform 
activity. Eur. J. Neurosci. 2011, 33, 482–498. 
42. Mukherjee, S.; Tessema, M.; Wandinger-Ness, A. Vesicular trafficking of tyrosine kinase 
receptors and associated proteins in the regulation of signaling and vascular function. Circ. Res. 
2006, 98, 743–756. 
43. Orth, J.D.; McNiven, M.A. Get off my back! Rapid receptor internalization through circular 
dorsal ruffles. Cancer Res. 2006, 66, 11094–11096. 
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
